“Levothyroxine reduced monocyte release of TNF-α, IL-1β, IL-6, and monocyte chemoattractant protein-1, whereas selenomethionine inhibited lymphocyte release of IL-2 , interferon-γ, and TNF-α, which was accompanied by a reduction in plasma CRP levels.”